Amin GasmiSadaf NoorTorsak TippairoteMaryam DadarAlain MenzelGeir BjørklundCouncil for Nutritional and Environmental MedicineRazi Vaccine & Serum Research Institute, IranLaboratoires Reunis Kutter-Lieners-Hastert Centre LangwiesBahauddin Zakariya UniversityMahidol UniversitySociété Francophone de Nutrithérapie et de Nutrigénétique AppliquéeBBH Hospital2020-06-022020-06-022020-06-01Clinical Immunology. Vol.215, (2020)15217035152166162-s2.0-85084738239https://repository.li.mahidol.ac.th/handle/20.500.14594/56202© 2020 Elsevier Inc. It is an ugly fact that a significant amount of the world's population will contract SARS-CoV-II infection with the current spreading. While a specific treatment is not yet coming soon, individual risk assessment and management strategies are crucial. The individual preventive and protective measures drive the personal risk of getting the disease. Among the virus-contracted hosts, their different metabolic status, as determined by their diet, nutrition, age, sex, medical conditions, lifestyle, and environmental factors, govern the personal fate toward different clinical severity of COVID-19, from asymptomatic, mild, moderate, to death. The careful individual assessment for the possible dietary, nutritional, medical, lifestyle, and environmental risks, together with the proper relevant risk management strategies, is the sensible way to deal with the pandemic of SARS-CoV-II.Mahidol UniversityImmunology and MicrobiologyMedicineIndividual risk management strategy and potential therapeutic options for the COVID-19 pandemicReviewSCOPUS10.1016/j.clim.2020.108409